Pfizer R&D: A Unique Approach for Success
Pfizer’s operating model is designed to ensure strong alignment between the Worldwide R&D (WRD) group and the commercial businesses.
The WRD group is responsible for potential therapies from discovery through the proof of concept (POC) stage, such POC stage typically being a Phase 2 study. The focus of Pfizer’s early research is to develop potential new and important medicines for patients. Pfizer is engaging in collaborations to help drive early stage pre-POC research efforts and to expedite the translation of scientific knowledge into potential next generation therapies.
Throughout the research and development continuum, Pfizer's 11 research units and three business units are supported by multiple partner lines that are responsible for designing and optimizing our drugs and vaccines. These partner lines include Medicinal Chemistry, Pharmaceutical Sciences, Drug Safety, Regulatory and Development Operations. The partner lines possess critical expertise intended to optimize each therapy for patients and the marketplace.